Discovering biomarkers to improve heart transplant outcomes
Multi-omic Biomarker Discovery and Validation in Heart Transplant Patient Populations
This study is looking at how new technologies can help find important signs in heart transplant patients to better predict and manage issues like rejection, so that doctors can provide more personalized care and improve recovery for those patients.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | New York University School of Medicine NIH-funded |
| Lab location | 1 site (New York, United States) |
| Project ID | NIH-10997887 on NIH RePORTER |
What this research studies
This research investigates how advanced technologies can identify biomarkers in heart transplant patients to better predict and manage complications like acute rejection. By analyzing various biological data, including genomic and proteomic information, the study aims to enhance the precision of diagnoses and treatment strategies for heart transplant recipients. The approach involves integrating multiple types of biological data to create a comprehensive profile of each patient, which could lead to more personalized care and improved survival rates.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals who have undergone or are scheduled for heart transplantation.
Not a fit: Patients who are not heart transplant recipients or those with contraindications for transplantation may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to improved survival rates and better management of heart transplant patients through personalized treatment strategies.
How similar studies have performed: Other research has shown promise in using multi-omic approaches to improve patient outcomes in various medical fields, suggesting potential success for this novel application in heart transplantation.
Where this research is happening
New York, United States
- New York University School of Medicine — New York, United States (Active)
Researchers
- Principal investigator: Keating, Brendan James — New York University School of Medicine
- Study coordinator: Keating, Brendan James
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.